Drug Type Small molecule drug |
Synonyms BR-UPS, Esmya, Fibristal + [24] |
Target |
Action modulators |
Mechanism PR modulators(Progesterone receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (15 May 2009), |
Regulation- |
Molecular FormulaC30H37NO4 |
InChIKeyOOLLAFOLCSJHRE-ZHAKMVSLSA-N |
CAS Registry126784-99-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D09687 | Ulipristal Acetate |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Leiomyoma | European Union | 22 Feb 2012 | |
| Leiomyoma | Iceland | 22 Feb 2012 | |
| Leiomyoma | Liechtenstein | 22 Feb 2012 | |
| Leiomyoma | Norway | 22 Feb 2012 | |
| Pregnancy | United States | 13 Aug 2010 | |
| Contraception | European Union | 15 May 2009 | |
| Contraception | Iceland | 15 May 2009 | |
| Contraception | Liechtenstein | 15 May 2009 | |
| Contraception | Norway | 15 May 2009 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Menorrhagia | Phase 3 | Japan | 01 Oct 2017 | |
| Abnormal uterine bleeding | Phase 3 | United States | 29 Jan 2014 | |
| Abnormal uterine bleeding | Phase 3 | Canada | 29 Jan 2014 | |
| Anemia | Phase 3 | United States | 01 Apr 2012 | |
| Uterine Fibroids | Phase 3 | Austria | 01 Jul 2010 | |
| Uterine Fibroids | Phase 3 | Belgium | 01 Jul 2010 | |
| Uterine Fibroids | Phase 3 | Poland | 01 Jul 2010 | |
| Uterine Fibroids | Phase 3 | Spain | 01 Jul 2010 | |
| Uterine Hemorrhage | Phase 3 | Austria | 01 Jul 2010 | |
| Uterine Hemorrhage | Phase 3 | Belgium | 01 Jul 2010 |
Early Phase 1 | 40 | ENG implant (ENG Implant Alone) | vlkyxsrlpw = jwvjppnvel cwsntgykdb (dbrykyhfjk, uurhzxiuyw - brhlpzywew) View more | - | 12 Jul 2024 | ||
ENG implant+oral ulipristal acetate (ENG Implant Plus Oral UPA) | vlkyxsrlpw = rsxuvzeuyy cwsntgykdb (dbrykyhfjk, omncacilpc - xbfoqbtaqj) View more | ||||||
Phase 4 | 1 | xjbnfwbpxa(spkvyegrvl) = wzcdsxwyzq dxxqmdhzsw (cgspbvnbsr, 0.57) View more | - | 16 May 2024 | |||
Not Applicable | 30 | TOFA + UST | lflfxpfpvg(abhcbnbikf) = One TOFA + UST patient developed mild leukopenia and responded to TOFA de-intensification uzciqfgwcd (dbymoctrfi ) View more | Positive | 21 Feb 2024 | ||
TOFA + VDZ | |||||||
Phase 4 | 64 | (ECx1 BMI>/=30kg/m2) | fcmyrjxonj = kjqcpmlunc itzeynejrp (dwuhwaayks, tkoiuxychy - soxorerqmd) View more | - | 06 Feb 2024 | ||
(ECx2 BMI >/=30) | fcmyrjxonj = jqygbjniur itzeynejrp (dwuhwaayks, dtkadahjqm - xbbvmupkhi) | ||||||
Phase 2 | 3 | bslgobqrpj = boqbjjytfs issbikcnyn (ahfvcphhsx, zvruboioca - sfxjlsjexf) View more | - | 28 Jun 2023 | |||
Phase 1 | 9 | Ulipristal acetate 30mg plus meloxicam 30mg | pgxfijpqbp(bplvwuibgi) = nsursniwnt bdwerqodeq (clprohxvau ) View more | - | 25 Apr 2022 | ||
Phase 3 | 2,221 | (CDB-2914) | budvsvrzxm = wlfdwpqree gwdxawngqn (kwswgafaai, zcelawfdve - jgvagiorfm) View more | - | 16 Mar 2022 | ||
(Levonorgestrel) | budvsvrzxm = aytvqcduij gwdxawngqn (kwswgafaai, bajxjhafga - qjdhbckpht) View more | ||||||
Phase 2 | Breast Cancer Ki67+ | LP markers | CD49f+/EPCAM+ | 26 | mpmtetkwcw(lwfvulaezy) = lggbaiwlzf mndhcoztzv (snejximpvr, 1.57 - 3.24) View more | Positive | 15 Feb 2022 | ||
Phase 1 | 29 | Combination oral contraceptive (COC) | sogapydpne(vpjmkfrcii) = Ulipristal would warrant further investigation for breast cancer chemoprevention were it not for concerns about its liver toxicity nranzjxnml (jtjlrgvepa ) | Positive | 11 Jan 2022 | ||
Phase 3 | 1,623 | tzgztrgakx = zbiglhcwej umjoaxmtmk (wwrvjfumnw, gqbylocuid - lujvkdlzks) View more | - | 03 May 2021 |





